Sepsis immune cell study ends early
NCT ID NCT03115125
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at a type of immune cell called regulatory B lymphocytes in 10 patients with severe sepsis in the intensive care unit. The goal was to track how these cells change over time after infection. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking antibiotic levels in the blood improve sepsis care?
- Blood filtering may save children with sepsis
- Can zinc help fight sepsis? early study explores dosing
- New blood marker could speed up sepsis diagnosis in emergency rooms
- Can less be more? study tests cutting back antibiotics in sepsis
- Massive data dive aims to tame sepsis in kids